NZYM-001

N/A

Report date: 2025/11/04 10:59:16

Base Information

Drug NameNZYM-001
Drug Alias Namefosamprenavir(N-Zyme Biomedical Inc)fosamprenavir oral tablets-LPR(N-Zyme Biomedical Inc)NZYM-001NZYM001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsLaryngopharyngeal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN-Zyme Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN-Zyme Biomedical Inc
Inactive CompaniesN/A
Active IndicationsLaryngopharyngeal Reflux
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A